Literature DB >> 9353227

Adenoviral vectors for gene transfer.

I Kovesdi1, D E Brough, J T Bruder, T J Wickham.   

Abstract

Adenoviruses began to be developed into highly effective gene expression vectors in the early 1980s. Recently, the increased interest in utilizing this transfer system in vivo has posed new problems for heterologous gene-transfer, spurring a renewed effort in the field of vector development toward solving the structural, immunological and targeting problems posed by gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353227     DOI: 10.1016/s0958-1669(97)80033-x

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  36 in total

Review 1.  Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Authors:  A T Parsa; A J Fiore; P C McCormick; J N Bruce
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.

Authors:  D J Von Seggern; S Huang; S K Fleck; S C Stevenson; G R Nemerow
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  A model for intracellular trafficking of adenoviral vectors.

Authors:  Anh-Tuan Dinh; Theo Theofanous; Samir Mitragotri
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

Review 4.  Animal transgenesis: state of the art and applications.

Authors:  Eduardo O Melo; Aurea M O Canavessi; Mauricio M Franco; Rodolfo Rumpf
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

Review 5.  Gene therapy for type 1 diabetes: is it ready for the clinic?

Authors:  Antonella D'Anneo; Pleunie Rood; Rita Bottino; A N Balamurugan; Jing He; Nick Giannoukakis
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

7.  Gene therapy, early promises, subsequent problems, and recent breakthroughs.

Authors:  Saeideh Razi Soofiyani; Behzad Baradaran; Farzaneh Lotfipour; Tohid Kazemi; Leila Mohammadnejad
Journal:  Adv Pharm Bull       Date:  2013-08-20

8.  Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.

Authors:  V Legrand; D Spehner; Y Schlesinger; N Settelen; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  PAd-shRNA-PTN reduces pleiotrophin of pancreatic cancer cells and inhibits neurite outgrowth of DRG.

Authors:  Jun Yao; Min Zhang; Qing-Yong Ma; Zheng Wang; Lian-Cai Wang; Dong Zhang
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 10.  Gene therapy for restenosis: current status.

Authors:  Juha Rutanen; Johanna Markkanen; Seppo Ylä-Herttuala
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.